Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buchler

Showing results (361-370 of 502) with videos related to

Pageof 51
Sort By:
Transplantation|September 24, 2011
Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantationPhilippe Gatault, Azmi Al-Najjar, Christelle Barbet, et al.
Cancer Management and Research|January 16, 2019
Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysisTomas Buchler, Renata Chloupkova, Alexandr Poprach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2025
PET imaging of cardiac sympathetic nervous system dysfunction using meta-[<sup>18</sup>F]fluorobenzylguanidineUzair S Ismailani, Ariel Buchler, Jadde de Carvalho Tso, et al.
DNA Repair|October 14, 2018
Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patientsSona Vodenkova, Katerina Jiraskova, Marketa Urbanova, et al.
Journal of Hypertension|September 21, 2022
End-diastolic velocity mediates the relationship between renal resistive index and the risk of deathJean-Michel Halimi, Louis-Marie Vernier, Juliette Gueguen, et al.
In Vivo (Athens, Greece)|November 4, 2020
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast CancerIveta Kolarova, Ladislav Dusek, Ales Ryska, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 15, 2015
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumabOndrej Fiala, Tomas Buchler, Beatrice Mohelnikova-Duchonova, et al.
Clinical Transplantation|November 26, 2009
Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantationC Morath, B Schmied, A Mehrabi, et al.
Oncotarget|January 7, 2016
Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeAlessio Naccarati, Fabio Rosa, Veronika Vymetalkova, et al.
Cancer Management and Research|August 6, 2020
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 PatientsAlena Novakova-Jiresova, Katerina Kopeckova, Ludmila Boublikova, et al.
Pageof 51

Showing results (361-370 of 502) with videos related to

Sort By:
Pageof 51
Transplantation|September 24, 2011
Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantationPhilippe Gatault, Azmi Al-Najjar, Christelle Barbet, et al.
Cancer Management and Research|January 16, 2019
Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysisTomas Buchler, Renata Chloupkova, Alexandr Poprach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2025
PET imaging of cardiac sympathetic nervous system dysfunction using meta-[<sup>18</sup>F]fluorobenzylguanidineUzair S Ismailani, Ariel Buchler, Jadde de Carvalho Tso, et al.
DNA Repair|October 14, 2018
Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patientsSona Vodenkova, Katerina Jiraskova, Marketa Urbanova, et al.
Journal of Hypertension|September 21, 2022
End-diastolic velocity mediates the relationship between renal resistive index and the risk of deathJean-Michel Halimi, Louis-Marie Vernier, Juliette Gueguen, et al.
In Vivo (Athens, Greece)|November 4, 2020
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast CancerIveta Kolarova, Ladislav Dusek, Ales Ryska, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 15, 2015
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumabOndrej Fiala, Tomas Buchler, Beatrice Mohelnikova-Duchonova, et al.
Clinical Transplantation|November 26, 2009
Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantationC Morath, B Schmied, A Mehrabi, et al.
Oncotarget|January 7, 2016
Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcomeAlessio Naccarati, Fabio Rosa, Veronika Vymetalkova, et al.
Cancer Management and Research|August 6, 2020
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 PatientsAlena Novakova-Jiresova, Katerina Kopeckova, Ludmila Boublikova, et al.
Pageof 51